Qube Research & Technologies LTD Molecular Partners Ag Call Options Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding MOLN
# of Institutions
9Shares Held
860KCall Options Held
0Put Options Held
0-
Bvf Inc San Francisco, CA443KShares$2.07 Million0.1% of portfolio
-
Suvretta Capital Management, LLC New York, NY400KShares$1.87 Million0.12% of portfolio
-
Old Mission Capital LLC10.4KShares$48,4040.0% of portfolio
-
Ubs Group Ag3.46KShares$16,1620.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.5KShares$11,6750.0% of portfolio
About MOLECULAR PARTNERS AG
- Ticker MOLN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,514,000
- Market Cap $152M
- Description
- Molecular Partners AG operates as a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic proteins. Its products candidates include Abicipar, a DARPin therapeutic candidate, which is in Phase III clinical trials for the treatment of neovascular wet age-related macular degeneration, ...